Current: Board member of several growing and private lifescience companies including Mereo Biopharma, COMPASS Pathways, K2 HealthVentures, Skye Bioscience, Affimed, Ori Biotech, Conduit Connect and Genomics England Former: President and CEO of Dimension Therapeutics; Science Board Committee Member to the US Food & Drug Administration; Chair of The Court for The London School of Hygiene and Tropical Medicine; Trustee of The King’s Fund, Cancer Research Horizons, British Heart Foundation